Aardvark Therapeutics, Inc.
Ownership
Ownership Structure
Who owns Aardvark Therapeutics, Inc. (AARD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 50.3% of the shares are freely tradable; institutional investors hold 56.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Decheng Capital LLC | 17.90 | 3,917,299 | +0.0 | 03/31/2026 |
| Citadel Advisors Llc | 5.86 | 1,283,166 | +3.2 | 06/30/2026 |
| LAURION CAPITAL MANAGEMENT LP | 4.73 | 1,034,459 | +1.9 | 03/31/2026 |
| BlackRock Inc | 3.62 | 792,571 | +1.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.53 | 554,101 | +0.0 | 03/31/2026 |
| EcoR1 Capital, LLC | 1.81 | 396,194 | +0.0 | 06/30/2026 |
| Geode Capital Management, LLC | 1.41 | 309,449 | +3.9 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 1.37 | 300,000 | +0.0 | 06/30/2026 |
| State Street Corp | 0.91 | 199,322 | +26.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 1.87 | 408,670 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Sun Nelson | See Remarks | 35,475 | 195,113 $ | Sep 11, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Sun Nelson | See Remarks | Sell | 62,000 | 5.18 | 321,179 |
| Sep 10, 2026 | Sun Nelson | See Remarks | Sell | 14,754 | 5.00 | 73,779 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.